[Informe de investigación] El mercado del corazón estructural se valoró en 14.245,55 millones de dólares en 2022 y se espera que alcance los 22.560,88 millones de dólares en 2028; se estima que registrará una tasa compuesta anual del 8,0 % entre 2022 y 2028.
El mercado del corazón estructural está segmentado según el producto, el procedimiento, el usuario final y la geografía. El informe ofrece información y un análisis en profundidad del mercado, enfatizando varios parámetros como la dinámica, las tendencias y las oportunidades del mercado y el análisis del panorama competitivo de los principales actores del mercado en varias regiones. También incluye un análisis del impacto de la pandemia de COVID-19 en el mercado en todas las regiones.
Mercado del corazón estructural, conocimientos estratégicos
Mercado del corazón estructural, conocimientos del mercado
El creciente número de casos de enfermedades cardiovasculares y los programas de capacitación impulsan el mercado del corazón estructural
Según la Organización Mundial de la Salud (OMS), las enfermedades cardiovasculares son la segunda causa de muerte en todo el mundo. Por ello, se están tomando diversas iniciativas para controlar la incidencia de enfermedades cardiovasculares. La enfermedad de las válvulas cardíacas es una de las causas más comunes de insuficiencia cardíaca. Las enfermedades degenerativas de las válvulas aórtica y mitral y las enfermedades de las válvulas tricúspide disfuncionales conducen a un peor curso clínico en los casos graves. Las intervenciones mínimamente invasivas, quirúrgicas y basadas en catéteres para la enfermedad cardíaca estructural han aumentado dramáticamente recientemente. La hoja informativa del Reino Unido de enero de 2022, publicada por la British Heart Foundation (BHF), muestra que ~7,6 millones de personas con enfermedades cardiovasculares viven en el Reino Unido. Según la misma fuente, ~4 millones de hombres y ~3,6 millones de mujeres fueron diagnosticados con enfermedades cardíacas y circulatorias en el país en 2021. Debido a la alta incidencia de enfermedades cardiovasculares, existe una gran demanda de procedimientos de tratamiento como la angioplastia y la cirugía cardíaca. cirugía para la supervivencia, que crea oportunidades para que las empresas proporcionen válvulas cardíacas estructurales y anillos de anuloplastia, entre otros dispositivos.
El corazón estructural es un campo en evolución que consiste en cirugías de válvulas cardíacas y procedimientos transcatéter; por ello, se están organizando diversos programas de formación para cirujanos cardíacos y médicos. Durante la última década, la creciente incidencia de enfermedades cardíacas estructurales ha requerido el desarrollo de programas de capacitación formales para garantizar la competencia adecuada de la fuerza laboral. La estructura, duración y alcance de la capacitación varían mucho entre programas. La mayoría de los programas brindan capacitación efectiva sobre procedimientos de reemplazo valvular aórtico transcatéter (TAVR), brindando simultáneamente una experiencia menor y variable en el cierre de la comunicación interauricular o interventricular y en las intervenciones de cierre de la orejuela auricular izquierda. Con la llegada de TAVR, el sistema de reparación de la válvula mitral MitraClip (Abbott Vascular) y los procedimientos de oclusión de la orejuela auricular izquierda (LAAO), ha habido un aumento significativo en el volumen de procedimientos cardíacos estructurales realizados para el tratamiento de pacientes con afecciones cardiovasculares complejas. Muchas organizaciones han desarrollado servicios y ofertas de procedimientos en un formato organizado para que el programa cardíaco estructural se adapte a la afluencia de pacientes. La formación en SHD es emocionante, desafiante y gratificante en general. A medida que el campo evoluciona, la estandarización de la formación en SHD se vuelve extremadamente importante para garantizar la mejor calidad de atención al paciente. Un mentor puede ayudar a navegar por las numerosas consideraciones descritas y puede ser el mejor activo para realizar una transición exitosa de la capacitación a la práctica.
A continuación se muestra la lista de programas de capacitación disponibles en los EE. UU. para los procedimientos cardíacos estructurales:
Programas de entrenamiento cardíaco estructural en EE. UU.
Sr. No | Programa | Estado |
| < p>1 | Programa de la Universidad de Washington Centro Médico Sueco en Seattle, WA | Washington |
2 | Programa del Sistema de Salud Main Line/Centro Médico Lankenau < p>Hospital Universitario Thomas Jefferson | Pensilvania |
3 | Programa del Hospital Presbiteriano de Nueva York (campus de Columbia) Centro médico Langone de la Facultad de Medicina de la Universidad de Nueva York Escuela de Medicina Icahn en Mount Sinai Lenox Hill Heart and Vascular Institute-Northwell Health Centro médico Montefiore La Universidad de Buffalo – ndash; Universidad Estatal de Nueva York | Nueva York |
4 | Programa del Hospital de la Universidad de Duke Programa del Centro Médico UNC | Carolina del Norte |
5 | Escuela de Medicina Rutgers Robert Wood Johnson - New Brunswick, Nueva Jersey Programa de becas para enfermedades cardíacas estructurales y congénitas en el Centro Médico de la Universidad de Hackensack y en el Hospital Infantil Joseph M Sanzari Centro Médico de la Universidad de Hackensack | Nueva Jersey |
6 | Clínica Scripps/Programa Scripps Green Hospital Beca de atención cardíaca estructural e intervencionista avanzada de Sharp Healthcare Universidad de California, Davis, Programa de Salud Universidad de California, San Diego Universidad de California, San Francisco | California |
7 | Programa de la Universidad de Maryland Programa de la Universidad Johns Hopkins | Maryland |
8 | Programa del Hospital William Beaumont Centro Médico de Detroit/Programa de la Universidad Estatal Wayne Hospital Henry Ford/Programa de la Universidad Estatal Wayne Ascension Borgess— Programa de la Universidad Estatal de Michigan Medicina de Michigan: programa de la Universidad de Michigan | Michigan |
Programa de la Universidad Emory | Georgia | |
10 | Programa Phoenix del Centro Médico Banner-University Centro Médico de Tucson/THMEP | Arizona |
Fuente: Sociedad de Angiografía e Intervenciones Cardiovasculares (SCAI )
Por lo tanto, el creciente número de casos de enfermedades cardiovasculares y los programas de capacitación sobre el corazón estructural están impulsando el crecimiento del mercado del corazón estructural.
Información basada en productos
Según el producto, el mercado del corazón estructural se segmenta en oclusores, anillos de anuloplastia, balones de válvula cardíaca y otros. En 2022, el segmento de oclusores poseía la mayor participación del mercado de corazones estructurales; sin embargo, se prevé que el segmento de anillos de anuloplastia registre la CAGR más alta durante el período de pronóstico. Los oclusores son uno de los productos más utilizados debido a la creciente prevalencia de defectos cardíacos congénitos, como defecto del tabique auricular, defecto del tabique ventricular, conducto arterioso persistente y agujero oval permeable. Los oclusores ayudan en el tratamiento de defectos cardíacos congénitos mediante procedimientos mínimamente invasivos, que brindan opciones de tratamiento sencillas y una recuperación rápida a los pacientes.
Mercado estructural del corazón, por producto: 2022-2028
Mercado estructural del corazón, según información basada en procedimientos
Según el procedimiento, el mercado estructural del corazón se segmenta en estenosis de válvula cardíaca, reemplazo de válvula cardíaca y cierre de la orejuela auricular izquierda . En 2022, el segmento de estenosis de la válvula aórtica tenía la mayor cuota de mercado del mercado del corazón estructural. Sin embargo, se prevé que el segmento de cierre del apéndice auricular izquierdo registre la CAGR más alta durante el período de pronóstico.
Mercado estructural del corazón, según información basada en el usuario final
Basado en el usuario final, el El mercado estructural del corazón se segmenta en hospitales, centros quirúrgicos ambulatorios y centros cardíacos. El segmento de hospitales tuvo la mayor participación en el mercado del corazón estructural en 2022 y se espera que registre la CAGR más alta durante el período de pronóstico.
Los actores del mercado del corazón estructural adoptan estrategias orgánicas, como el lanzamiento y la expansión de productos. , para expandir su presencia y cartera de productos en todo el mundo y satisfacer la creciente demanda. Las estrategias de crecimiento inorgánico observadas en el mercado son asociaciones y colaboraciones. Estas estrategias de crecimiento han permitido a los actores del mercado expandir sus negocios y mejorar su presencia geográfica. Además, las adquisiciones, asociaciones y otras estrategias de crecimiento ayudan a fortalecer la base de clientes de la empresa y aumentar su cartera de productos.
- En febrero de 2023, Medtronic relanzó su Harmony Transcatheter Sistema de válvula pulmonar (TPV), una alternativa mínimamente invasiva a la cirugía a corazón abierto para pacientes con enfermedades cardíacas congénitas con tracto de salida del ventrículo derecho (TSVD) nativo o reparado quirúrgicamente.
- En noviembre de 2022, Boston Scientific Corporation lanzó el primeros resultados del estudio de seguimiento clínico poscomercialización (PMCF) de ACURATE neo2 que evalúa el rendimiento del sistema de válvula aórtica ACURATE neo2TM. Los hallazgos, que incluyeron una alta tasa de éxito del procedimiento del 98,4 % y bajas tasas de mortalidad y fuga paravalvular (PVL), se presentaron durante una sesión de ensayo clínico de última hora en PCR London Valves 2022.
- En octubre de 2022 , El equipo del Centro Médico para Mujeres y Niños de Guangzhou implantó con éxito Memosorb en un niño con una enfermedad cardíaca congénita. La finalización exitosa de esta operación marca que la aplicación clínica del oclusor ha dado un paso esencial en el sur de China, lo que confirma una vez más la seguridad y eficacia del Memosorb en el tratamiento intervencionista de las cardiopatías congénitas.
Mercado del corazón estructural, perfiles de empresas
- Laboratorios Abbott
- Medtronic Plc
- Boston Scientific Corp
- Artivion Inc.
- Edwards Lifesciences Corp
- Lepu Medical Technology Beijing Co Ltd
- Braile Biomédica Industry
- Commerce and Representations Ltd
- Aran Biomedical Teoranta
- Micro Interventional Devices Inc
- Corcym UK Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. Most structural heart conditions are present since birth (congenital), but these can also be acquired later in life owing to wear & tear from infection. Advancements in the medical field have replaced open-heart surgical procedures with minimally invasive procedures. The devices that are used in structural heart disease comprise replacement and repair devices, such as devices that are used for the treatment of heart-related diseases. Structural heart devices comprise annuloplasty rings and heart valve balloons occluders, among others.
The structural heart market is expected to be valued at US$ 22,560.88 million in 2028.
The structural heart market was valued at US$ 14,245.55 million in 2022.
The structural heart market majorly consists of the players, such as Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc., Edwards Lifesciences Corp, Lepu Medical Technology Beijing Co Ltd, Braile Biomédica Industry, Commerce and Representations Ltd, Aran Biomedical Teoranta, Micro Interventional Devices Inc, Corcym UK Ltd.
The factors driving the structural heart market growth, includes innovative structural heart services, and a rise in the number of cardiovascular procedures and corresponding training programs boost the market growth.
The market is estimated to grow at a CAGR of 8.0% during the forecast period.
The structural heart market, by product, is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest market share in 2022, however, annuloplasty rings is anticipated to register the highest CAGR in the market during the forecast period.
The List of Companies - Structural Heart Market
- ABBOTT
- MEDTRONIC
- BOSTON SCIENTIFIC CORPORATION
- CRYOLIFE, INC
- EDWARD LIFESCIENCES CORPORATION
- LEPU MEDICAL
- BRAILE BIOMEDICA
- ARAN BIOMEDICAL TEORANTA
- Micro Interventional Devices, Incorporated
- CORCYM
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2023
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2023
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2023
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)